Clinical trial Recruiting at 3 sites Observational Ages 18 to 65

PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury

Official title: Deployment of a Novel NINDS Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for ED Patients With GCS 15 TBI (PIONEER-Prognosis)

Run by University of Michigan · NCT07858266 · Data updated 2026-11-12

This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.

More Traumatic Brain Injury trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations5 sites (Torrance, California and 4 other locations)
StatusRecruiting
StartedOctober 20, 2026
Main results expectedDecember 31, 2028
Study endsAugust 30, 2029
Registry record updatedNovember 10, 2026
Trial IDNCT07858266 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with mild TBI (GCS 15) presenting within 24 hours of injury and who will wear a health-monitoring device for 3 months and participate in follow-up assessments.

Probably not a fit

Patients with pre-existing neurological disabilities or conditions that would preclude accurate prognosis, or those unlikely to adhere to device wear and follow-up, may derive little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PIONEER-Prognosis study is a multicenter, prospective observational effort enrolling adults 18–65 with mild TBI and a GCS of 15 within 24 hours of injury. It applies the NINDS CBI-M framework, combining biomarker data (GFAP and UCH-L1), CT results, and psychosocial factors to predict long-term recovery. Participants wear a WHOOP device for 90 days and provide blood samples and clinical information at the ED, with follow-up assessments by phone at 14 and 90 days. The goal is to determine how well this integrated framework can forecast outcomes and inform clinical management after head injury.

Why it matters

Potential benefit: If successful, clinicians could better predict recovery trajectories and tailor monitoring and counseling for patients after mild TBI.

How similar studies have gone: Previous work in TBI prognosis has shown promise with biomarker and imaging approaches, but this framework combining biomarkers, imaging, and modifiers in an ED setting is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of mild traumatic brain injury (TBI), as defined by the 2023 American Congress of Rehabilitation Medicine (ACRM) criteria.
* Enrollment within 24 hours of injury.
* Glasgow Coma Scale (GCS) score of 15 at emergency department (ED) enrollment.
* Consent to study procedures, including:

  * Blood collection for biomarker measurement, including glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1).
  * Continuous use of a health-monitoring device for 3 months.
  * Follow-up assessments by telephone at 14 days and 90 days.
  * Completion of a daily symptom inventory via WHOOP/smartphone.

Exclusion Criteria:

* Pre-existing neurological disability or pre-injury condition that would have resulted in a Glasgow Outcome Scale-Extended (GOS-E) score \<8 if assessed before the injury.
* High risk of loss to follow-up, including patients without a reliable phone, those experiencing homelessness, those who are incarcerated, or those who are wards of the state.
* Pregnancy at the time of enrollment.
* Inability to speak English or Spanish, which would prevent completion of the required assessments.

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • Henry Ford Macomb
    Clinton Township, Michigan, United States
    Recruiting
  • Henry Ford Hospital
    Detroit, Michigan, United States
    Recruiting
  • Harbor-UCLA Medical Center
    Torrance, California, United States
    Not yet recruiting
  • Oregon Health & Science University
    Portland, Oregon, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Frederick Korley, MD, PhD — University of Michigan
  • Study coordinator: Devon Newman, MS
  • Email: devonn@med.umich.edu
  • Phone: 734-764-1602

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

    This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

    Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

  • Depth Electrode Monitoring after Traumatic Brain Injury

    This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.

    Recruiting Hennepin Healthcare Research Institute · Minneapolis, Minnesota · NCT07842458

  • Understanding growth hormone deficiency after a brain injury in adults

    This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.

    Recruiting University of Calgary · Calgary, Alberta and 1 other locations · NCT07795736

  • Electrical stimulation-assisted exercise for people with lower limb paralysis

    This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.

    Recruiting Louis Stokes VA Medical Center · Cleveland, Ohio · NCT07768761

  • ZEPU-2000 robotic rehab for arm and leg weakness

    This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.

    Recruiting Bangladesh Medical University · Dhaka · NCT07749612

  • ZEPU-SG1PLUS Hand Training with Robotic Rehab for Arm Problems

    A small study tests whether adding the ZEPU-SG1PLUS robotic hand trainer to standard rehab is safe and helps people with arm problems after stroke, spinal cord injury, brain injury, or orthopedic injuries.

    Recruiting Bangladesh Medical University · Dhaka · NCT07739264

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.